Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
19.97
-2.55 (-11.32%)
At close: Apr 4, 2025, 4:00 PM
21.00
+1.03 (5.16%)
After-hours: Apr 4, 2025, 7:35 PM EDT
Apellis Pharmaceuticals (APLS) Product Revenue by Segment
History
| Date | Syfovre | Empaveli |
|---|---|---|
| Dec 31, 2024 | 611.85M | 98.13M |
| Sep 30, 2024 | 558.35M | 99.13M |
| Jun 30, 2024 | 481.67M | 98.42M |
| Mar 31, 2024 | 394.39M | 96.21M |
| Dec 31, 2023 | 275.28M | 91.04M |
| Sep 30, 2023 | 160.98M | 86.34M |
| Jun 30, 2023 | 85.70M | 80.14M |
| Mar 31, 2023 | 18.36M | 73.49M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.